Precision Nanotechnology & Targeted Delivery
Engineering sophisticated nano-architectures to strictly control pharmacokinetic exposure, bypass biological barriers, and maximise clinical efficacy.
The Limits of Conventional Delivery
Many next-generation therapeutics—particularly highly potent oncology assets and complex biologics—fail in the clinic due to severe off-target toxicity or rapid systemic clearance. When sponsors attempt to force these sensitive molecules into conventional dosage forms, they encounter insurmountable biological barriers, premature degradation, and narrow therapeutic windows that ultimately compromise patient safety and trial viability.
Advanced Nano-Architecture
We engineer delivery systems as complex as the molecules they protect. As your technical co-architects, Dhee Lifesciences designs highly specialised targeted therapies, including lipid nanoparticles (LNPs), polymeric micelles, and liposomal dispersions. By precisely manipulating particle size, zeta potential, and encapsulation efficiency, we guide your asset directly to the target microenvironment, ensuring controlled release and unparalleled in vivo stability.
Accelerated by the SynapTx™ AI Ecosystem
Engineering at the nanoscale requires immense computational precision. SynapTx™ parses decades of dense peer-reviewed literature to model complex release kinetics and polymer degradation profiles before physical formulation begins. By computationally mapping non-obvious correlations between nano-excipients and target tissues, our local AI platform allows us to mathematically optimise formulation parameters for maximum cellular uptake.